Total Hip Arthroplasty—Current Challenges

Dear Colleagues,

In 1891, Professor Themistocles Glück in Germany was the first to replace a femoral head in hip joints destroyed by tuberculosis using ivory, followed by Marius Smith-Petersen in 1925 using a mold arthroplasty out of glass. Further attempts in hip joint replacement followed until Sir Jon Charnely significantly advanced total hip arthroplasty in the 1960s. In the following decades, further innovations in materials and design enhanced the outcome. As a result of the enhanced survivorship and low revision rates in 2007, total hip replacement was called the “operation of the century”. However, due to an increasing number of performed total hip arthroplasties in an aging population, hip surgeons have to face various challenges in 2021 and in the near future.

The aim and scope of this Special Issue is to discuss current and future challenges in primary and revision total hip arthroplasty (THA) such as (i) primary complex THA (Perthes diseases, DDH, post-traumatic conditions, acetabular fractures, bone loss/osteolysis, osteoporosis), (ii) complication management (instability, infection, periprosthetic fractures at the femoral and acetabular site), (iii) in specific patients (young, very demanding, older adults, obesity, dissatisfied patients, when to deny a total hip), (iv) modern patient management protocols (prehabilitation, enhanced recovery protocols, fast track surgery, orthogeriatric co-management), (v) outcome analysis (focus on PROMS, predictors and strategies to improve satisfaction), (vi) revision surgery (cement in cement, modularity, dual mobility, trunnionosis, metallosis, pseudotumor), and (vii) new technologies in cutting-edge research topics (robotic surgery, virtual versus augmented reality, 3D printing, learning curves, teaching).

We are soliciting preclinical studies (anatomical, biomechanical, technical reports) and clinical studies (PROM, outcome, registry data, epidemiological), with a focus on original articles. For the submission of reviews, reporting according to the PRISMA guidelines is required.

Prof. Dr. Johannes Dominik Bastian
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.